The type II transforming growth factor-β receptor as a tumor-suppressor gene

Michael G. Brattain, Sanford D. Markowitz, James K V Willson

Research output: Contribution to journalReview article

66 Scopus citations

Abstract

Recent work has shown that: 1) loss of transforming growth factor-β response is associated with malignant progression, 2) maintenance of autocrine negative transforming growth factor-activity is a key impediment to malignant progression, and 3) the major mechanism for loss of RII expression in replication error-positive colorectal cancer patients is mutation of the poly A tract of the transforming growth factor-β receptor type II (RII) gene resulting in the generation of a premature STOP codon. Major issues for the role of RII in cancer are identified as the determination of the penetrance of mechanisms of RII loss in non-replication error tumors and other types of malignancies in addition to colon cancer. Analysis of mechanism of RII loss may prove to have clinical use in defining the clinical course of subset of different types of malignancies and, in addition, it may result in the identification of new therapeutic targets and approaches for some subsets of cancers.

Original languageEnglish (US)
Pages (from-to)49-53
Number of pages5
JournalCurrent Opinion in Oncology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 1996

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this